Marathon of the Messenger
Marathon of the Messenger
A History of Messenger RNA Vaccines
Lemonnier, Jerome; Pichon, Chantal; Meulien, Pierre; Lemonnier, Nicolas; Pascolo, Steve; Charrot, Gilles
Springer International Publishing AG
11/2023
202
Mole
Inglês
9783031392993
15 a 20 dias
Descrição não disponível.
Chapter 1. Introduction: The Marathon of the Messenger RNA.- Part I. Messenger RNA, an essential role and challenge.- Chapter 2. A short history of vaccination.- Chapter 3. From DNA to RNA.- Chapter 4. Messenger RNA (mRNA): from transcription to protein translation.- Chapter 5. The mechanism of viral infection.- Chapter 6. The immune response.- Part II. From preliminary studies to clinical trials.- Chapter 7. Promising studies in the 1990s.- Chapter 8. The use of mRNA - the initial technical obstacles.- Chapter 9. The birth of CureVac: the era of the pioneers.- Chapter 10. Solutions for mRNA optimization.- Chapter 11. Modified and unmodified mRNA: for what purpose?.- Chapter 12. Experiments and clinical trials conducted: the power of therapeutic mRNA.- Chapter 13. Experiments and clinical trials against infectious diseases.- Chapter 14. Experiments and clinical trials against cancer.- Chapter 15. Experiments and clinical trials carried out in other therapeutic fields.- Chapter 16. Modified mRNA versus unmodified mRNA: not just a scientific issue.- Part III. The triumph of messenger RNA.- Chapter 17. A very progressive diffusion in scientific circles.- Chapter 18. The development of future biotechs in the 2010s.- Chapter 19. The importance of intellectual property and patents.- Chapter 20. 2020: the triumph of anti-Covid mRNA vaccines.- Chapter 21. mRNA, a technology of the future.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
biotechs;mRNA;biotechnology;patents;BioNTech;vaccines;Moderna;CureVac
Chapter 1. Introduction: The Marathon of the Messenger RNA.- Part I. Messenger RNA, an essential role and challenge.- Chapter 2. A short history of vaccination.- Chapter 3. From DNA to RNA.- Chapter 4. Messenger RNA (mRNA): from transcription to protein translation.- Chapter 5. The mechanism of viral infection.- Chapter 6. The immune response.- Part II. From preliminary studies to clinical trials.- Chapter 7. Promising studies in the 1990s.- Chapter 8. The use of mRNA - the initial technical obstacles.- Chapter 9. The birth of CureVac: the era of the pioneers.- Chapter 10. Solutions for mRNA optimization.- Chapter 11. Modified and unmodified mRNA: for what purpose?.- Chapter 12. Experiments and clinical trials conducted: the power of therapeutic mRNA.- Chapter 13. Experiments and clinical trials against infectious diseases.- Chapter 14. Experiments and clinical trials against cancer.- Chapter 15. Experiments and clinical trials carried out in other therapeutic fields.- Chapter 16. Modified mRNA versus unmodified mRNA: not just a scientific issue.- Part III. The triumph of messenger RNA.- Chapter 17. A very progressive diffusion in scientific circles.- Chapter 18. The development of future biotechs in the 2010s.- Chapter 19. The importance of intellectual property and patents.- Chapter 20. 2020: the triumph of anti-Covid mRNA vaccines.- Chapter 21. mRNA, a technology of the future.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.